BioSpace News Archive

the world’s leading chemical vendor BOC Sciences announced to upgrade its chiral analysis and separation service for the pharmaceutical industry to support scientists’ needs arising from drug testing after all the preliminary work of lead discovery in the early stages.

Integrity Marketing Group, LLC (“Integrity”), the nation’s largest independent distributor of life and health insurance products, today announced it has completed its acquisition of American Senior Benefits, one of the largest career agency distribution networks in the country. Based in Kansas City, American Senior Benefits is focused entirely on serving the Senior Market, which aligns perfectly with Integrity’s core markets

Lonza has selected Rockwell Automation for the turnkey implementation of the Lonza strategic vision of bringing the digital factory to nine former Capsugel facilities that manufacture drug capsules.

Group K Diagnostics (GKD), a biotechnology innovator aiming to overhaul the diagnostic process for both patient and caregiver, plans to attend the upcoming 71st American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California from August 4-8.

The National Science Teaching Association, the largest professional organization in the world promoting excellence and innovation in science teaching and learning for all, welcomed five new members to its Board of Directors and six new members to its Council last month.

With the introduction of a Medication Tourism program that makes specialty pharmaceuticals, vaccines and specialized care conveniently available to patients at up to 80 percent savings, Bumrungrad International Hospital (BIH) takes the lead in improving access to high quality care and prescriptions at significantly lower costs for complex diseases such as rheumatoid arthritis, HIV, Hepatitis C, multiple sclerosis, cancer and orphan/rare diseases.

Most people deem physician-prescribed medication safe and use it to alleviate their travel-related anxiety

Veteran Healthcare Executive to Continue to Accelerate Major Growth at Medical Device Manufacturer as CEO

According to Coherent Market Insights, the global companion diagnostics market was valued at US$ 2,040.0 million in 2017, and is projected to exhibit a CAGR of 19.5% over the forecast period (2018–2026).

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that J.J. Finkelstein, President and Chief Executive Officer, will present a corporate update at the Rodman & Renshaw 21st Annual Global Investment Conference on September 8-10, 2019